Unicycive To Ring the Nasdaq Closing Bell on March 29, 2022
March 23, 2022 08:30 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today...
Unicycive Announces Acceptance of Two Preclinical Data Sets to be Presented at the European Renal Association Congress
March 16, 2022 08:37 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today...